SageTech Medical, a pioneer in sustainability for both the medical and veterinary sectors, is excited to announce that it has received funding from Innovate UK. This will support the upscaling of its revolutionary process for capturing, recovering, and purifying waste volatile anaesthetic agents. It is not commonly known that these agents, which are potent greenhouse gases, contribute over 3M tonnes of CO2 equivalent emissions across the globe annually.
Launched in January 2023, SageTech’s volatile anaesthetic waste capture technology has already seen commercial success in the UK, and significant interest in overseas markets. There are no existing technologies that can match the performance of SageTech’s processes in terms of efficiency (resource preservation) and carbon savings.
Earlier this month, Innovate UK chose SageTech Medical, in collaboration with the University of Plymouth, as one of the winners of a grant competition which will support the upscaling of their recovery and purification capacity. This upscaled capacity will support rapid and modular expansion across new markets including EU, USA, and beyond. In doing so, SageTech will create a global model for medicines manufacturing that is sustainable and scalable. This initiative not only promises to advance sustainability goals of anaesthetic delivery but also aims to protect the UK from global disruptions and supply chain pressures, such as those experienced during the COVID-19 pandemic.
Steve Wileman, Head of Research at SageTech Medical said: “Our commitment to innovation and sustainability is at the core of everything we do at SageTech Medical. We are very pleased to be working again with our academic partners at the University of Plymouth to deliver this exciting project.”
This project underscores SageTech Medical’s mission to lower carbon emissions in healthcare by tackling an issue that is often overlooked through innovative solutions, and leading the way in sustainable anaesthesia.